Newborn screening in southeastern Europe

Autor:	Barbka Repic Lampret, Mariana Muresan, Husref Tahirović, Maria Ivanova, Maja Stojiljkovic, Mojca Zerjav Tansek, Mira Samardzic, Adil Kadam, Tadej Battelino, Otilia Margineanu, Urh Groselj, Oana Marginean, Florentina Moldovanu, Vjosa Kotori, Michaela Iuliana Nanu, Simona Murko, Ivo Barić, Olivera Milijanovic, Natalija Angelkova, Dana Anton, Vladimir Sarnavka, Alma Toromanovic, Radka Tincheva, Aleksei Savov, Natalia Usurelu, Maja Djordjevic, Biljana Suzic, Hajrija Maksic, Andraz Smon, Lindita Grimci
Rok vydání:	2014
Předmět:	Pediatrics medicine.medical_specialty Endocrinology Diabetes and Metabolism Developing country neonatal screening southeastern Europe Biochemistry Neonatal Screening Endocrinology Phenylketonurias Environmental health Congenital Hypothyroidism Genetics Humans Mass Screening Medicine Molecular Biology Newborn screening business.industry Genetic Diseases Inborn Infant Newborn food and beverages medicine.disease 3. Good health Congenital hypothyroidism Europe embryonic structures business
Zdroj:	Molecular Genetics and Metabolism. 113:42-45
ISSN:	1096-7192
DOI:	10.1016/j.ymgme.2014.07.020
Popis:	The aim of our study was to assess the current state of newborn screening (NBS) in the region of southeastern Europe, as an example of a developing region, focusing also on future plans. Responses were obtained from 11 countries. Phenylketonuria screening was not introduced in four of 11 countries, while congenital hypothyroidism screening was not introduced in three of them ; extended NBS programs were non-existent. The primary challenges were identified. Implementation of NBS to developing countries worldwide should be considered as a priority.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d48bdfca6067b7f131d7470e65c1549 https://doi.org/10.1016/j.ymgme.2014.07.020 Zobrazit plný text záznamu Full Text from ScienceDirect